These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 2370612)

  • 21. Cysteine in the triple-helical domain of one allelic product of the alpha 1(I) gene of type I collagen produces a lethal form of osteogenesis imperfecta.
    Steinmann B; Rao VH; Vogel A; Bruckner P; Gitzelmann R; Byers PH
    J Biol Chem; 1984 Sep; 259(17):11129-38. PubMed ID: 6469997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.
    Starman BJ; Eyre D; Charbonneau H; Harrylock M; Weis MA; Weiss L; Graham JM; Byers PH
    J Clin Invest; 1989 Oct; 84(4):1206-14. PubMed ID: 2794057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gly802Asp substitution in the pro alpha 2(I) collagen chain in a family with recurrent osteogenesis imperfecta due to paternal mosaicism.
    Lund AM; Schwartz M; Raghunath M; Steinmann B; Skovby F
    Eur J Hum Genet; 1996; 4(1):39-45. PubMed ID: 8800927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagen.
    Sarafova AP; Choi H; Forlino A; Gajko A; Cabral WA; Tosi L; Reing CM; Marini JC
    Hum Mutat; 1998; 11(5):395-403. PubMed ID: 9600458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of overmodified type I procollagen in a case of osteogenesis imperfecta.
    Tajima S; Takehana M; Azuma N
    J Dermatol; 1994 Apr; 21(4):219-22. PubMed ID: 8056893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Nicholas Andry Award-1996. The molecular pathology of osteogenesis imperfecta.
    Cole WG
    Clin Orthop Relat Res; 1997 Oct; (343):235-48. PubMed ID: 9345229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type I collagen biosynthesis by skin fibroblasts from patients with idiopathic juvenile osteoporosis.
    Pocock AE; Francis MJ; Smith R
    Clin Sci (Lond); 1995 Jul; 89(1):69-73. PubMed ID: 7671570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta.
    Valli M; Rossi A; Forlino A; Tenni R; Cetta G
    Matrix; 1993 Jul; 13(4):275-80. PubMed ID: 8412984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moderately severe osteogenesis imperfecta: biochemical studies showing variable defect localization in the triple-helical domain of type I collagen.
    Valli M; Tenni R; Cetta G
    Matrix; 1990 Jul; 10(3):200-5. PubMed ID: 2215359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.
    Constantinou CD; Nielsen KB; Prockop DJ
    J Clin Invest; 1989 Feb; 83(2):574-84. PubMed ID: 2913053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta.
    Bonadio J; Holbrook KA; Gelinas RE; Jacob J; Byers PH
    J Biol Chem; 1985 Feb; 260(3):1734-42. PubMed ID: 2981871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered relation of two collagen types in osteogenesis imperfecta.
    Sykes B; Francis MJ; Smith R
    N Engl J Med; 1977 May; 296(21):1200-3. PubMed ID: 857159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secreted collagen ratios in normal human and osteogenesis imperfecta skin fibroblasts.
    Fraser J; Lancaster GA; Scriver CR
    Connect Tissue Res; 1983; 11(1):57-67. PubMed ID: 6221880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical variability of osteogenesis imperfecta linked to COL1A2 and associated with a structural defect in the type I collagen molecule.
    Superti-Furga A; Pistone F; Romano C; Steinmann B
    J Med Genet; 1989 Jun; 26(6):358-62. PubMed ID: 2567784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered collagen metabolism in osteogenesis imperfecta fibroblasts: a study on 33 patients with diverse forms.
    Brenner RE; Vetter U; Nerlich A; Wörsdorfer O; Teller WM; Müller PK
    Eur J Clin Invest; 1990 Feb; 20(1):8-14. PubMed ID: 2108039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen.
    Shapiro JR; Stover ML; Burn VE; McKinstry MB; Burshell AL; Chipman SD; Rowe DW
    J Clin Invest; 1992 Feb; 89(2):567-73. PubMed ID: 1737847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation in the carboxy-terminal propeptide of the Pro alpha 1(I) chain of type I collagen in a child with severe osteogenesis imperfecta (OI type III): possible implications for protein folding.
    Oliver JE; Thompson EM; Pope FM; Nicholls AC
    Hum Mutat; 1996; 7(4):318-26. PubMed ID: 8723681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of mutant alpha (I)-procollagen in osteoblast and fibroblast cultures from a proband with osteogenesis imperfecta type IV.
    Chipman SD; Shapiro JR; McKinstry MB; Stover ML; Branson P; Rowe DW
    J Bone Miner Res; 1992 Jul; 7(7):793-805. PubMed ID: 1642148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on type I collagen in skin fibroblasts cultured from twins with lethal osteogenesis imperfecta.
    Galicka A; Wołczyński S; Gindzieński A
    Acta Biochim Pol; 2003; 50(2):481-8. PubMed ID: 12833172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dominant mutations in familial lethal and severe osteogenesis imperfecta.
    Cohen-Solal L; Bonaventure J; Maroteaux P
    Hum Genet; 1991 Jul; 87(3):297-301. PubMed ID: 1864604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.